Manhattan Scientifics, Inc.
MHTX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,454 | $4,474 | $8,948 | $23,812 |
| - Cash | $67 | $175 | $232 | $353 |
| + Debt | $60 | $110 | $130 | $104 |
| Enterprise Value | $1,447 | $4,409 | $8,846 | $23,563 |
| Revenue | $0 | $50 | $50 | $50 |
| % Growth | -100% | 0% | 0% | – |
| Gross Profit | -$1 | $50 | $50 | $50 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$1,164 | -$2,706 | -$3,611 | $4,341 |
| % Margin | – | -5,412% | -7,222% | 8,682% |
| Net Income | -$1,165 | -$2,730 | -$3,639 | $4,314 |
| % Margin | – | -5,460% | -7,278% | 8,628% |
| EPS Diluted | -0.002 | -0.005 | -0.007 | 0.007 |
| % Growth | 57.1% | 24.6% | -189% | – |
| Operating Cash Flow | -$190 | -$349 | -$421 | -$388 |
| Capital Expenditures | $0 | $0 | $0 | -$4 |
| Free Cash Flow | -$190 | -$349 | -$421 | -$392 |